Aging researchNeurodegenerationMetabolism

2025

Case StudyCase Study

RNA interference (RNAi) in C. elegans: A powerful tool for gene function and therapeutic discovery

The discovery of RNA interference (RNAi) in C. elegans transformed how we study and manipulate genes. Today, this same mechanism that was once a curiosity of basic biology is the foundation of life-saving RNA therapeutics like Onpattro® and Venclexta®.
In C. elegans, RNAi can spread systemically, silencing genes throughout the whole organism, and it can be triggered simply by feeding bacteria engineered to produce double-stranded RNA.
With ready-to-use bacterial libraries targeting nearly every C. elegans gene, we can:
  • Silence single or multiple genes in vivo.
  • Model disease-relevant phenotypes.
  • Validate human-relevant targets before mammalian studies.